Skip to content

Kimberley Breen

Royal Ottawa Health Care Group/Director, Patient Care Services / Directrice, Services de soins aux patients

2025 Salary

$141,449

Total compensation $141,996, including $548 in taxable benefits.

Source: Ontario’s Public Sector Salary Disclosure — names paid $100,000 or more that year. How we build this · Report an error on this page

At a Glance
2025

Employer Rank

#80

Royal Ottawa Health Care Group

Years on List

8

2018–2025

Peak Salary

$141,449

2025

Full 2025 roster at Royal Ottawa Health Care Group·See where $141,449 ranks →

Total Compensation History

Total compensation by yearLine chart of 8 yearly values of total compensation, from $100,717 in 2018 to $141,996 in 2025.$100K$110K$120K$130K$140K$150K201820192021202220242025
Total compensation, 2018–2025. Axis starts at $100,000, the Sunshine List disclosure threshold.

Full History
20182025

Take-Home Pay
(After Tax) · 2025 estimate

Of the $141,449 Kimberley Breen earned in 2025, roughly $99,030 would remain after income tax, CPP and EI, an all-in deduction rate of about 30.0%. It is up about 8% on the $131,316 paid in 2024. Records under this name have appeared on the Sunshine List 8 years in all, first in 2018. Pension contributions — likely HOOPP in the Hospitals & Boards of Public Health sector — would typically trim another 7–10% off that figure.

Estimated net pay
~$99,030
Effective income-tax rate (excl. CPP/EI)
~26.1%
CPP + EI contributions
~$5,507
All-in deduction rate (incl. CPP/EI)
~30.0%
vs. 2025 Director Patient Care Services median
about even

Where does $141,449 rank on the Sunshine List? →

Estimate only: 2025 federal and Ontario rates, basic personal amounts, Canada employment amount and CPP/EI credits; single, employment income only, salary treated as full-year income. Ignores pension contributions (OMERS, HOOPP, OTPP, OPTrust and similar plans lower actual take-home), union dues, RRSPs and benefits.

Also at Royal Ottawa Health Care Group
2025

View all 513 employees at Royal Ottawa Health Care Group (2025) →